Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Clinical Practice Guidelines – Neurotoxicity

Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up

Published in 2020 – Ann Oncol (2020)
Authors: B. Jordan, A. Margulies, F. Cardoso, G. Cavaletti, H. S. Haugnes, P. Jahn, E. Le Rhun, M. Preusser, F. Scotté, M. J. B. Taphoorn & K. Jordan

These Guidelines were developed by the European Society for Medical Oncology (ESMO), the European Oncology Nursing Society (EONS) and the European Association of Neuro-Oncology (EANO).

This ESMO–EONS–EANO Clinical Practice Guideline provides key recommendations on the management of therapy-induced peripheral and central neurotoxicity. Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe and abroad. Recommendations are based on available scientific data and the authors’ collective expert opinion. An algorithm on the practical approach to assessing chemotherapy-induced peripheral neurotoxicity is provided.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings